• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review.

作者信息

Rubatto Marco, Merli Martina, Avallone Gianluca, Agostini Andrea, Mastorino Luca, Caliendo Virginia, Barcellini Amelia, Vitolo Viviana, Valvo Francesca, Fierro Maria Teresa, Ribero Simone, Quaglino Pietro

机构信息

Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.

National Center of Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.

出版信息

Oncotarget. 2022 Aug 4;13:985. doi: 10.18632/oncotarget.28265.

DOI:10.18632/oncotarget.28265
PMID:36455565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9359457/
Abstract
摘要

相似文献

1
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review.附录：着色性干皮病的免疫治疗：1例使用西米普利单抗治疗的晚期皮肤鳞状细胞癌病例及文献综述
Oncotarget. 2022 Aug 4;13:985. doi: 10.18632/oncotarget.28265.
2
Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review.着色性干皮病的免疫治疗：1例用西米普利单抗治疗的晚期皮肤鳞状细胞癌病例及文献综述
Oncotarget. 2021 May 25;12(11):1116-1121. doi: 10.18632/oncotarget.27966.
3
Re-irradiation of metastatic disease in the neck from xeroderma pigmentosum.着色性干皮病颈部转移性疾病的再放疗。
Curr Oncol. 2010 Jun;17(3):83-5. doi: 10.3747/co.v17i3.479.
4
Recurrent squamous cell carcinoma and a novel mutation in a patient with xeroderma pigmentosum: a case report.色素性干皮病患者复发性鳞状细胞癌及新突变：病例报告。
J Med Case Rep. 2022 Jul 28;16(1):306. doi: 10.1186/s13256-022-03524-2.
5
Xeroderma pigmentosum: a case report and review of the literature.着色性干皮病：一例病例报告及文献综述
J Prev Med Hyg. 2010 Jun;51(2):87-91.
6
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.西妥昔单抗治疗局部晚期皮肤鳞状细胞癌：一项开放标签、2 期、单臂试验的结果。
Lancet Oncol. 2020 Feb;21(2):294-305. doi: 10.1016/S1470-2045(19)30728-4. Epub 2020 Jan 14.
7
Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience in a Monographic Oncology Center.西妥昔单抗联合化疗一线治疗转移性结直肠癌的疗效和安全性：一项单中心回顾性研究
Actas Dermosifiliogr. 2022 Jun;113(6):T610-T615. doi: 10.1016/j.ad.2022.05.001. Epub 2022 May 4.
8
Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience in a Monographic Oncology Center.西妥昔单抗治疗晚期皮肤鳞状细胞癌的真实世界经验：单中心单组研究
Actas Dermosifiliogr. 2022 Jun;113(6):610-615. doi: 10.1016/j.ad.2021.04.011. Epub 2022 Mar 7.
9
A case of lip squamous cell carcinoma with a familial history of Xeroderma pigmentosum.一例伴有家族性着色性干皮病病史的唇鳞状细胞癌。
Oral Oncol. 2020 Dec;111:104896. doi: 10.1016/j.oraloncology.2020.104896. Epub 2020 Jul 10.
10
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.西妥昔单抗在局部晚期和转移性皮肤鳞状细胞癌中的真实世界数据。
Eur J Cancer. 2021 Nov;157:250-258. doi: 10.1016/j.ejca.2021.08.018. Epub 2021 Sep 15.